Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 50

1.

Dynamic 2D and 3D mapping of hyperpolarized pyruvate to lactate conversion in vivo with efficient multi-echo balanced steady-state free precession at 3 T.

Müller CA, Hundshammer C, Braeuer M, Skinner JG, Berner S, Leupold J, Düwel S, Nekolla SG, Månsson S, Hansen AE, von Elverfeldt D, Ardenkjaer-Larsen JH, Schilling F, Schwaiger M, Hennig J, Hövener JB.

NMR Biomed. 2020 Mar 10:e4291. doi: 10.1002/nbm.4291. [Epub ahead of print]

PMID:
32154970
2.

Comparison of simultaneous arterial spin labeling MRI and 15O-H2O PET measurements of regional cerebral blood flow in rest and altered perfusion states.

Puig O, Henriksen OM, Vestergaard MB, Hansen AE, Andersen FL, Ladefoged CN, Rostrup E, Larsson HB, Lindberg U, Law I.

J Cereb Blood Flow Metab. 2019 Sep 9:271678X19874643. doi: 10.1177/0271678X19874643. [Epub ahead of print]

PMID:
31500521
3.

Preparing data for multiparametric PET/MR imaging: Influence of PET point spread function modelling and EPI distortion correction on the spatial correlation of [18F]FDG-PET and diffusion-weighted MRI in head and neck cancer.

Olin A, Krogager L, Rasmussen JH, Andersen FL, Specht L, Beyer T, Kjaer A, Fischer BM, Hansen AE.

Phys Med. 2019 May;61:1-7. doi: 10.1016/j.ejmp.2019.04.006. Epub 2019 Apr 17.

4.

18F-FDG PET/MR-imaging in a Göttingen Minipig model of atherosclerosis: Correlations with histology and quantitative gene expression.

Ludvigsen TP, Pedersen SF, Vegge A, Ripa RS, Johannesen HH, Hansen AE, Löfgren J, Schumacher-Petersen C, Kirk RK, Pedersen HD, Christoffersen BØ, Ørbæk M, Forman JL, Klausen TL, Olsen LH, Kjaer A.

Atherosclerosis. 2019 Jun;285:55-63. doi: 10.1016/j.atherosclerosis.2019.04.209. Epub 2019 Apr 9.

PMID:
31004968
5.

PET/DW-MRI for evaluating treatment in chronic hepatitis C patients.

Petersen RJ, Nielsen NS, Johannesen HH, Hansen AE, Jespersen S, Arnbjerg CJ, Löfgren J, Kjær MS, Clausen MR, Kjær A, Nielsen SD, Fischer BM.

Am J Nucl Med Mol Imaging. 2019 Feb 15;9(1):84-92. eCollection 2019.

6.

Development of a Symmetric Echo-Planar Spectroscopy Imaging Framework for Hyperpolarized 13C Imaging in a Clinical PET/MR Scanner.

Eldirdiri A, Posse S, Hanson LG, Hansen RB, Holst P, Schøier C, Kristensen AT, Johannesen HH, Kjaer A, Hansen AE, Ardenkjaer-Larsen JH.

Tomography. 2018 Sep;4(3):110-122. doi: 10.18383/j.tom.2018.00006.

7.

Simultaneous characterization of tumor cellularity and the Warburg effect with PET, MRI and hyperpolarized 13C-MRSI.

Hundshammer C, Braeuer M, Müller CA, Hansen AE, Schillmaier M, Düwel S, Feuerecker B, Glaser SJ, Haase A, Weichert W, Steiger K, Cabello J, Schilling F, Hövener JB, Kjær A, Nekolla SG, Schwaiger M.

Theranostics. 2018 Sep 9;8(17):4765-4780. doi: 10.7150/thno.25162. eCollection 2018.

8.

Feasibility of multi-parametric PET and MRI for prediction of tumour recurrence in patients with glioblastoma.

Lundemann M, Munck Af Rosenschöld P, Muhic A, Larsen VA, Poulsen HS, Engelholm SA, Andersen FL, Kjær A, Larsson HBW, Law I, Hansen AE.

Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):603-613. doi: 10.1007/s00259-018-4180-3. Epub 2018 Oct 2.

PMID:
30276440
9.

Phase contrast mapping MRI measurements of global cerebral blood flow across different perfusion states - A direct comparison with 15O-H2O positron emission tomography using a hybrid PET/MR system.

Puig O, Vestergaard MB, Lindberg U, Hansen AE, Ulrich A, Andersen FL, Johannesen HH, Rostrup E, Law I, Larsson HB, Henriksen OM.

J Cereb Blood Flow Metab. 2019 Dec;39(12):2368-2378. doi: 10.1177/0271678X18798762. Epub 2018 Sep 11.

10.

Components of day-to-day variability of cerebral perfusion measurements - Analysis of phase contrast mapping magnetic resonance imaging measurements in healthy volunteers.

Ismaili ARA, Vestergaard MB, Hansen AE, Larsson HBW, Johannesen HH, Law I, Henriksen OM.

PLoS One. 2018 Jun 7;13(6):e0197807. doi: 10.1371/journal.pone.0197807. eCollection 2018.

11.

Effect of Lactobacillus rhamnosus GG Supplementation on Intestinal Inflammation Assessed by PET/MRI Scans and Gut Microbiota Composition in HIV-Infected Individuals.

Arnbjerg CJ, Vestad B, Hov JR, Pedersen KK, Jespersen S, Johannesen HH, Holm K, Halvorsen B, Fallentin E, Hansen AE, Lange T, Kjær A, Trøseid M, Fischer BM, Nielsen SD.

J Acquir Immune Defic Syndr. 2018 Aug 1;78(4):450-457. doi: 10.1097/QAI.0000000000001693.

PMID:
29874201
12.

Combined hyperpolarized 13C-pyruvate MRS and 18F-FDG PET (hyperPET) estimates of glycolysis in canine cancer patients.

Hansen AE, Gutte H, Holst P, Johannesen HH, Rahbek S, Clemmensen AE, Larsen MME, Schøier C, Ardenkjaer-Larsen J, Klausen TL, Kristensen AT, Kjaer A.

Eur J Radiol. 2018 Jun;103:6-12. doi: 10.1016/j.ejrad.2018.02.028. Epub 2018 Feb 25.

13.

Reproducibility of MR-Based Attenuation Maps in PET/MRI and the Impact on PET Quantification in Lung Cancer.

Olin A, Ladefoged CN, Langer NH, Keller SH, Löfgren J, Hansen AE, Kjær A, Langer SW, Fischer BM, Andersen FL.

J Nucl Med. 2018 Jun;59(6):999-1004. doi: 10.2967/jnumed.117.198853. Epub 2017 Nov 9.

14.

A Prospective Study Comparing 99mTc-Hydroxyethylene-Diphosphonate Planar Bone Scintigraphy and Whole-Body SPECT/CT with 18F-Fluoride PET/CT and 18F-Fluoride PET/MRI for Diagnosing Bone Metastases.

Löfgren J, Mortensen J, Rasmussen SH, Madsen C, Loft A, Hansen AE, Oturai P, Jensen KE, Mørk ML, Reichkendler M, Højgaard L, Fischer BM.

J Nucl Med. 2017 Nov;58(11):1778-1785. doi: 10.2967/jnumed.116.189183. Epub 2017 Aug 10.

15.

Aggression-related brain function assessed with the Point Subtraction Aggression Paradigm in fMRI.

Skibsted AP, Cunha-Bang SD, Carré JM, Hansen AE, Beliveau V, Knudsen GM, Fisher PM.

Aggress Behav. 2017 Nov;43(6):601-610. doi: 10.1002/ab.21718. Epub 2017 Jul 25.

PMID:
28744913
16.

A multi-centre evaluation of eleven clinically feasible brain PET/MRI attenuation correction techniques using a large cohort of patients.

Ladefoged CN, Law I, Anazodo U, St Lawrence K, Izquierdo-Garcia D, Catana C, Burgos N, Cardoso MJ, Ourselin S, Hutton B, Mérida I, Costes N, Hammers A, Benoit D, Holm S, Juttukonda M, An H, Cabello J, Lukas M, Nekolla S, Ziegler S, Fenchel M, Jakoby B, Casey ME, Benzinger T, Højgaard L, Hansen AE, Andersen FL.

Neuroimage. 2017 Feb 15;147:346-359. doi: 10.1016/j.neuroimage.2016.12.010. Epub 2016 Dec 14.

17.

Optimized MLAA for quantitative non-TOF PET/MR of the brain.

Benoit D, Ladefoged CN, Rezaei A, Keller SH, Andersen FL, Højgaard L, Hansen AE, Holm S, Nuyts J.

Phys Med Biol. 2016 Dec 21;61(24):8854-8874. Epub 2016 Dec 2.

PMID:
27910823
18.

Feasibility of Multiparametric Imaging with PET/MR in Head and Neck Squamous Cell Carcinoma.

Rasmussen JH, Nørgaard M, Hansen AE, Vogelius IR, Aznar MC, Johannesen HH, Costa J, Engberg AM, Kjær A, Specht L, Fischer BM.

J Nucl Med. 2017 Jan;58(1):69-74. doi: 10.2967/jnumed.116.180091. Epub 2016 Sep 8.

19.

Simultaneous PET/MRI with (13)C magnetic resonance spectroscopic imaging (hyperPET): phantom-based evaluation of PET quantification.

Hansen AE, Andersen FL, Henriksen ST, Vignaud A, Ardenkjaer-Larsen JH, Højgaard L, Kjaer A, Klausen TL.

EJNMMI Phys. 2016 Dec;3(1):7. doi: 10.1186/s40658-016-0143-6. Epub 2016 Apr 22.

20.

In Vivo Phenotyping of Tumor Metabolism in a Canine Cancer Patient with Simultaneous (18)F-FDG-PET and Hyperpolarized (13)C-Pyruvate Magnetic Resonance Spectroscopic Imaging (hyperPET): Mismatch Demonstrates that FDG may not Always Reflect the Warburg Effect.

Gutte H, Hansen AE, Larsen MM, Rahbek S, Johannesen HH, Ardenkjaer-Larsen J, Kristensen AT, Højgaard L, Kjaer A.

Diagnostics (Basel). 2015 Jun 26;5(3):287-9. doi: 10.3390/diagnostics5030287.

Supplemental Content

Loading ...
Support Center